“Back then very few people thought that an inhibitor of this newly discovered aspartic protease had a chance of becoming an orally bioavailable drug, but nearly two decades later, these are ...

Recently, a third family of antivirals started to be used clinically (in addition to reverse transcriptase and protease inhibitors), with the advent of enfuvirtide (T20), the first fusion ...